Evidence map›Paper›PMID 38725769›Full record

ReviewCureus2024

Efficacy of Topical Treatments in the Management of Mild-to-Moderate Acne Vulgaris: A Systematic Review.

Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Tuheen Sankar Nath

Registry-linked trialAbstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07473895 (Efficacy and Safety of Topical 5% Spironolactone Gel Nano-Formulation Versus 0.1% Adapalene Gel in the Management of Acne Vulgaris), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07473895 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Topical 5% Spironolactone Gel Nano-Formulation Versus 0.1% Adapalene Gel in the Management of Acne Vulgaris: A Split-Face Study

TypeinterventionalSponsorAssiut UniversityRan2026 to 2026Enrolled40ConditionsAcne VulgarisArmsSpironolactone 5% Topical Gel, Adapalene 0.1% Topical Gel
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdulaziz AlthwanayDermatology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Esraa M AlEdaniDermatology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Harleen KaurInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Malik KasapogluInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Rajesh YadavalliInternal Medicine, Rajiv Gandhi Institute of Medical Sciences, Adilabad, IND.
Sarosh NawazPsychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Tuheen Sankar NathSurgical Oncology, Tata Medical Centre, Kolkata, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acne vulgaris, commonly called acne, is a skin condition affecting many individuals globally. It is a chronic condition characterized by developing pimples, blackheads (open comedones), whiteheads (closed comedones), and other skin lesions. Acne usually appears on the face, neck, chest, and back. It is commonly associated with puberty and adolescence but can also affect adults of all ages. Acne can be very frustrating and embarrassing, leading to low self-esteem and social isolation. The condition arises from various factors, including clogged pores, excessive sebum production, bacteria, and inflammation. This systematic review assesses the effectiveness of topical antibiotics, retinoids, niacinamide, azelaic acid, and clascoterone in treating mild-to-moderate acne vulgaris. A comprehensive search across PubMed, PubMed Central, and Google Scholar yielded 10 articles focused on topical antibiotics, with findings from 198 subjects indicating the efficacy of doxycycline against inflammatory lesions. Retinoids, such as tretinoin and adapalene, significantly improved both lesion types (open and closed comedones). Niacinamide, examined in a randomized controlled trial involving 41 participants, reduced sebum production. Another study with 60 patients revealed that azelaic acid effectively reduced both inflammatory and non-inflammatory lesions. Clascoterone emerged as a promising antiandrogenic treatment, supported by a randomized controlled trial involving 4,440 patients. It is essential that individualized therapy, incorporating patient preferences and considering adverse effects, is emphasized for optimizing acne management.

Indexed as

acne managementacne vulgarisinflammatory lesionsmild to moderate acnetopical treatments

Identifiers

PMID38725769
PMCPMC11081083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.